BRCA1 and neoplasm: Recently, the evidence that about 1/3 of BRCA1/2 pathogenic variants in OC patients are confined to the tumor tissue [4,10], has led to a recommendation that BRCA analysis be performed on DNA extracted from cancer tissue, in order to detect both the constitutional and the somatic variants [16].